Hydrea

In some countries, this medicine may only be approved for veterinary use.

In the US, Hydrea (hydroxyurea systemic) is a member of the drug class antimetabolites and is used to treat Anemia - Sickle Cell, Chronic Myelogenous Leukemia, Polycythemia Vera and Solid Tumors.

US matches:

• Hydrea

UK matches:

• Hydrea Capsules 500mg
• Hydrea 500 mg Hard Capsules (SPC)

Ingredient matches for Hydrea

Hydroxycarbamide

Hydroxycarbamide is reported as an ingredient of Hydrea in the following countries:

• Algeria


• Australia


• Bahrain


• Belgium


• Brazil


• Canada


• Chile


• Colombia


• Denmark


• Egypt


• Estonia


• Finland


• Georgia


• Hong Kong


• Indonesia


• Iran


• Iraq


• Ireland


• Japan


• Jordan


• Kuwait


• Latvia


• Lebanon


• Lithuania


• Luxembourg


• Netherlands


• New Zealand


• Oman


• Portugal


• Qatar


• Romania


• Saudi Arabia


• Singapore


• South Africa


• Spain


• Sweden


• Syria


• Taiwan


• Thailand


• Tunisia


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.